Schisandrin B alleviated CCl4-induced liver inflammation and fibrosis by inhibiting macrophage polarization by targeting peroxisome proliferator-activated receptor gamma (PPARγ) (Chen et al., 2021). This evidence concerns the gene PPARG and Hepatitis.